UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2019.
Commission File Number: 001-38524
Titan Medical Inc.
(Exact Name of Registrant as Specified in Charter)
170 University Avenue, Suite 1000
Toronto, Ontario M5H 3B3
Canada
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☐ Form 40-F ☒
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrants home country), or under the rules of the home country exchange on which the registrants securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrants security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Exhibits 99.1, 99.2 and 101 on this Report on Form 6-K will be deemed to be incorporated by reference into the Registrants Form F-3 registration statement filed on July 30, 2019 (File No. 333-232898)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
TITAN MEDICAL INC. | ||||||
(Registrant) | ||||||
Date: November 14, 2019 | By: | /s/ Stephen Randall | ||||
Name: | Stephen Randall | |||||
Title: | Chief Financial Officer |
EXHIBIT INDEX
99.1 | Unaudited Condensed Interim Financial Statements Three and Nine Months Ended September 30, 2019 and 2018 | |
99.2 | Managements Discussion and Analysis for the Three and Nine Months Ended September 30, 2019 | |
99.3 | Form 52-109F2 Certification of Interim Filings (CEO) | |
99.4 | Form 52-109F2 Certification of Interim Filings (CFO) |
XBRL | ||
101.INS | XBRL Instance | |
101.SCH | XBRL Taxonomy Extension Schema | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase | |
101.LAB | XBRL Taxonomy Extension Label Linkbase | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase |